In the wake of COVID-19, there has been an increase in cyber attacks targeting the life sciences sector. Life Sciences, even more
than other sectors, is regularly targeted through social engineering by cyber adversaries.
This guidance provides pragmatic advice on how Life Science company leaders can protect themselves. Following this advice will
reduce both your own and your organisation’s exposure to cybersecurity risk and assure prospective investors that the intellectual
property (IP) upon which the value of the company is based is suitably protected.
This content is restricted to members. To view this content please register or login below to view this content.